- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Marker Therapeutics Inc.
Headquarters: DE, United States
Website: https://markertherapeutics.co...
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Juan F. Vera, MD
Number Of Employees: 5
Enterprise Value: $8,736,004
PE Ratio: -0.95
Exchange/Ticker 1: NASDAQ:MRKR
Exchange/Ticker 2: N/A
Latest Market Cap: $12,898,900
BioCentury | Jun 28, 2024
Management Tracks
Forbion taps Dyne vet Brumm to guide growing U.S. presence
Plus: Edward Dulac to become CFO at Intellia, and updates from Altimmune, Bayer, Compass, Sensorion and Neurona
BioCentury | Apr 11, 2023
Management Tracks
Legend hires Koneru as CMO
Plus: Erasca promotes Morris, Lovejoy and updates from Poseida, Mithra, Tune, Cellarity and more
BioCentury | Oct 28, 2020
Product Development
Data Byte: FOLR1 pipeline for cancer
At least four antibody-drug conjugates, one antibody and two vaccines targeting FOLR1 are in development to treat cancer. The lead program is in Phase III testing for ovarian cancer.
BioCentury | May 3, 2019
Emerging Company Profile
Vineti: Keeping cell therapies on track
How Vineti's GMP-ready platform connects the cell therapy supply chain
Items per page:
1 - 10 of 10